| Cellular and molecular biomarkers of long COVID: a scoping review E Espín, C Yang, CP Shannon, S Assadian, D He, SJ Tebbutt EBioMedicine 91, 2023 | 60 | 2023 |
| Association of SARS-CoV-2 infection and persistence with long COVID C Yang, H Zhao, E Espín, SJ Tebbutt The Lancet Respiratory Medicine 11 (6), 504-506, 2023 | 46 | 2023 |
| Vaccine market and production capabilities in the Americas E Ortiz-Prado, E Espín, J Vásconez, N Rodríguez-Burneo, NC Kyriakidis, ... Tropical Diseases, Travel Medicine and Vaccines 7, 1-21, 2021 | 27 | 2021 |
| Analysis of health and drug access associated with the purchasing power of the ecuadorian population E Ortiz-Prado, J Ponce, F Cornejo-Leon, AM Stewart-Ibarra, RH Trujillo, ... Glob J Health Sci 9 (10.5539), 2017 | 27 | 2017 |
| A report of congenital adrenal hyperplasia due to 17α-hydroxylase deficiency in two 46, XX sisters F Espinosa-Herrera, E Espín, AM Tito-Álvarez, LJ Beltrán, ... Gynecological Endocrinology 36 (1), 24-29, 2020 | 14 | 2020 |
| Artificial infant formula consumption and breastfeeding trends in Ecuador, a population-based analysis from 2007 to 2014 E Ortiz-Prado, AM Stewart-Ibarra, D Ramirez, E Espín, A Morrison Global journal of health science 8 (11), 184, 2016 | 7 | 2016 |
| Is a higher altitude associated with shorter survival among at-risk neonates? I Dueñas-Espín, L Armijos-Acurio, E Espín, F Espinosa-Herrera, R Jimbo, ... PloS one 16 (7), e0253413, 2021 | 6 | 2021 |
| Perspectivas actuales sobre el uso terapéutico del veneno de serpientes E Ortiz Prado, C Molina, D Ramírez, E Espín, D Fierro VozAndes, 47-52, 2015 | 6 | 2015 |
| Effect of trastuzumab on the antiproliferative effects of PI3K inhibitors in HER2+ breast cancer cells with de novo resistance to trastuzumab. E Espin, JA Perez-Fidalgo, E Tormo, B Pineda, JM Cejalvo, MA Sabbaghi, ... Journal of Clinical Oncology 33 (15_suppl), e11592-e11592, 2015 | 4 | 2015 |
| False Positive Covid-19 Rapid Antigen Tests C Yang, E Espín, SJ Tebbutt The New England journal of medicine 390 (19), 1835-1836, 2024 | | 2024 |
| MicroRNAs in Breast Cancer: One More Turn in Regulation (vol 17, pg 1083, 2016) P Eroles, E Tormo, B Pineda, E Espin, A Lluch CURRENT DRUG TARGETS 17 (10), 1224-1224, 2016 | | 2016 |
| 160 AKT and/or mTOR inhibition as a potential target in trastuzumab resistant breast cancer cells with MUC-4 overexpression JA Perez-Fidalgo, E Espin, E Tormo, B Pineda, JM Cejalvo, MA Sabbaghi, ... European Journal of Cancer 3 (51), S17, 2015 | | 2015 |
| Perspectivas actuales sobre el uso terapéutico del veneno de serpientes E Espín, D Fierro Revista Médica Vozandes 25 (1-2), 2014 | | 2014 |
Anna M. Stewart IbarraInterAmerican Institute for Global Change Research (IAI)Dirección de correo verificada de dir.iai.int